Novo Nordisk sinks 15% after weight loss drug fails to match Eli Lilly's in trial
Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn't meet its primary target.
Last updated: 2026-02-23 18:01:35 ET
Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn't meet its primary target.
They're stressing about raising venture capital and product launches — not who they'll take to prom.
Milan-Cortina 2026 has been one of the most eventful Winter Olympics in history - in sporting and political terms - so it is appropriate that the final medal event could be the most enticing of all.
OpenAI said the account's activity did not meet the threshold to flag it to authorities when it was identified.
Grail’s stock was the Nasdaq’s biggest loser Friday, after a key trial of its Galleri early-detection cancer test failed to meet its primary endpo...
Anthropic doesn’t want its AI used in autonomous weapons or government surveillance. Those carve-outs could cost it a major military contract.
Inside Dewar’s cavernous whisky warehouses, man’s best mechanical friend—a Boston Dynamics robot dog with an ethanol sensor for a nose—is on t...
Walmart's 'AI-meets-retail' transformation is the pivotal story
Detroit has unveiled its Gen 6 heavy-duty engines for 2027. The updated DD13, DD15 and DD16 models meet the EPA’s stricter emissions standards while...
U.S. Southern Command leader makes visit to Venezuela after Nicolás Maduro's capture, meeting with interim leaders in Caracas to discuss securit...